- Home
- ADPT vs ACMR Comparison
ADPT vs ACMR Comparison
Compare ADPT & ACMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- ACMR
- Stock Information
- Founded
- ADPT 2009
- ACMR 1998
- Country
- ADPT United States
- ACMR United States
- Employees
- ADPT N/A
- ACMR N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- ACMR Industrial Machinery/Components
- Sector
- ADPT Health Care
- ACMR Technology
- Exchange
- ADPT Nasdaq
- ACMR Nasdaq
- Market Cap
- ADPT 1.8B
- ACMR 1.8B
- IPO Year
- ADPT 2019
- ACMR 2017
- Fundamental
- Price
- ADPT $12.61
- ACMR $29.86
- Analyst Decision
- ADPT Strong Buy
- ACMR Hold
- Analyst Count
- ADPT 8
- ACMR 3
- Target Price
- ADPT $12.38
- ACMR $27.00
- AVG Volume (30 Days)
- ADPT 1.8M
- ACMR 1.6M
- Earning Date
- ADPT 11-06-2025
- ACMR 11-06-2025
- Dividend Yield
- ADPT N/A
- ACMR N/A
- EPS Growth
- ADPT N/A
- ACMR 31.61
- EPS
- ADPT N/A
- ACMR 1.66
- Revenue
- ADPT $205,216,000.00
- ACMR $815,166,000.00
- Revenue This Year
- ADPT $32.76
- ACMR $18.90
- Revenue Next Year
- ADPT $15.81
- ACMR $15.92
- P/E Ratio
- ADPT N/A
- ACMR $18.02
- Revenue Growth
- ADPT 21.60
- ACMR 17.53
- 52 Week Low
- ADPT $3.98
- ACMR $13.87
- 52 Week High
- ADPT $13.68
- ACMR $32.54
- Technical
- Relative Strength Index (RSI)
- ADPT 51.14
- ACMR 59.13
- Support Level
- ADPT $12.34
- ACMR $26.44
- Resistance Level
- ADPT $13.68
- ACMR $29.49
- Average True Range (ATR)
- ADPT 0.56
- ACMR 1.44
- MACD
- ADPT -0.08
- ACMR 0.26
- Stochastic Oscillator
- ADPT 20.15
- ACMR 60.74
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About ACMR ACM Research Inc.
ACM Research Inc supplies advanced, innovative capital equipment developed for the world-wide semiconductor industry. Fabricators of advanced integrated circuits, or chips, can use its wet-cleaning and other front-end processing tools in numerous steps to improve product yield, even at increasingly advanced process nodes. It has designed these tools for use in fabricating foundry, logic and memory chips, including dynamic random-access memory, or DRAM, and 3D NAND-flash memory chips. The company also develops, manufactures and sells advanced packaging tools to wafer assembly and packaging customers.